Effects of Short-Chain Fructo-Oligosaccharides on Gut Bacteria
Author Information
Author(s): Yoram Bouhnik, Laurent Raskine, Guy Simoneau, Damien Paineau, Francis Bornet
Primary Institution: Hôpital Lariboisière, Paris, France
Hypothesis
Can short-chain fructo-oligosaccharides (scFOS) increase faecal bifidobacteria counts in healthy humans?
Conclusion
The study found that scFOS is bifidogenic and well tolerated at doses ranging from 2.5 to 10 g/d, showing a dose-response relationship.
Supporting Evidence
- Bifidobacteria counts increased significantly in the scFOS groups compared to placebo.
- A significant correlation was found between the dose of scFOS and faecal bifidobacteria counts.
- The study demonstrated that scFOS is well tolerated with mild digestive symptoms.
Takeaway
Eating certain sugars called scFOS can help good bacteria in your tummy grow, and it's safe to eat in small amounts.
Methodology
Forty healthy volunteers were given different doses of scFOS or a placebo for 7 days, and stool samples were analyzed for bacterial counts.
Limitations
The study had a relatively small sample size for each dose group, which may affect the power of the results.
Participant Demographics
18 males and 22 females, mean age 29 ± 1.3 years.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website